Published in Eur J Clin Microbiol Infect Dis on March 01, 2000
Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species. Antimicrob Agents Chemother (2001) 1.79
In vitro antibacterial activity and pharmacodynamics of new quinolones. Eur J Clin Microbiol Infect Dis (2003) 1.16
In vitro activities of a new des-fluoro(6) quinolone, garenoxacin, against clinical anaerobic bacteria. Antimicrob Agents Chemother (2003) 1.14
Resistance to moxifloxacin in toxigenic Clostridium difficile isolates is associated with mutations in gyrA. Antimicrob Agents Chemother (2001) 1.14
In vitro activity of moxifloxacin against 923 anaerobes isolated from human intra-abdominal infections. Antimicrob Agents Chemother (2006) 1.11
In vitro activities of moxifloxacin against 900 aerobic and anaerobic surgical isolates from patients with intra-abdominal and diabetic foot infections. Antimicrob Agents Chemother (2004) 1.06
Effects of exposure of Clostridium difficile PCR ribotypes 027 and 001 to fluoroquinolones in a human gut model. Antimicrob Agents Chemother (2008) 0.97
Alterations in DNA gyrase and topoisomerase IV in resistant mutants of Clostridium perfringens found after in vitro treatment with fluoroquinolones. Antimicrob Agents Chemother (2005) 0.87
Moxifloxacin in the treatment of skin and skin structure infections. Ther Clin Risk Manag (2006) 0.85
Clinical and microbiological efficacy of moxifloxacin versus amoxicillin/clavulanic acid in severe odontogenic abscesses: a pilot study. Eur J Clin Microbiol Infect Dis (2008) 0.84
Antimicrobial susceptibilities of Peptostreptococcus anaerobius and the newly described Peptostreptococcus stomatis isolated from various human sources. Antimicrob Agents Chemother (2007) 0.83
Bactericidal activities of methoxyfluoroquinolones gatifloxacin and moxifloxacin against aerobic and anaerobic respiratory pathogens in serum. Antimicrob Agents Chemother (2003) 0.82
Efficacy and safety of moxifloxacin in hospitalized patients with secondary peritonitis: pooled analysis of four randomized phase III trials. Surg Infect (Larchmt) (2014) 0.79
Activity of pradofloxacin against Porphyromonas and Prevotella spp. Implicated in periodontal disease in dogs: susceptibility test data from a European multicenter study. Antimicrob Agents Chemother (2008) 0.78
Acute cholecystitis - early laparoskopic surgery versus antibiotic therapy and delayed elective cholecystectomy: ACDC-study. Trials (2007) 0.75
Aetiology of antimicrobial-agent-associated colitis. Lancet (1978) 5.91
Evidence shows that cyclists should wear helmets. BMJ (1996) 5.86
Bacteriologic analysis of infected dog and cat bites. Emergency Medicine Animal Bite Infection Study Group. N Engl J Med (1999) 5.82
Bacteriology of human and animal bite wounds. J Clin Microbiol (1978) 2.66
EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect (2011) 2.65
Evaluation of the E test for susceptibility testing of anaerobic bacteria. J Clin Microbiol (1991) 2.59
Rapid identification of viridans streptococci by mass spectrometric discrimination. J Clin Microbiol (2007) 2.49
Staphylococcus intermedius in canine gingiva and canine-inflicted human wound infections: laboratory characterization of a newly recognized zoonotic pathogen. J Clin Microbiol (1989) 2.24
UNICEF's child injury league tables: a bag of mixed messages. Inj Prev (2001) 2.16
BMJ bans "accidents". BMJ (2001) 1.87
Saccharomyces cerevisiae infections in man. Sabouraudia (1984) 1.76
Evaluation of a novel specimen transport system (Venturi Transystem) for anaerobic bacteria. Clin Infect Dis (1997) 1.75
Effect of carbon dioxide on in vitro susceptibility of anaerobic bacteria to erythromycin. Antimicrob Agents Chemother (1981) 1.73
Characterization of saccharolytic Bacteroides and Prevotella isolates from infected dog and cat bite wounds in humans. J Clin Microbiol (1997) 1.68
Role of anaerobic bacteria in bite-wound infections. Rev Infect Dis (1984) 1.66
Comparative activity of the quinolones against anaerobic bacteria isolated at community hospitals. Antimicrob Agents Chemother (1985) 1.56
Infections caused by Klebsiella ozaenae: a changing disease spectrum. J Clin Microbiol (1978) 1.50
Cyclists should wear helmets. BMJ (1997) 1.49
Characterization of a beta-lactamase from Clostridium clostridioforme. J Antimicrob Chemother (1994) 1.47
Survival of aerobic and anaerobic bacteria in purulent clinical specimens maintained in the Copan Venturi Transystem and Becton Dickinson Port-a-Cul transport systems. J Clin Microbiol (2000) 1.41
Susceptibility of Eikenella corrodens to ten cephalosporins. Antimicrob Agents Chemother (1978) 1.35
Comparative susceptibilities of anaerobic bacteria to metronidazole, ornidazole, and SC-28538. Antimicrob Agents Chemother (1978) 1.32
Characterization of indole-negative Bacteroides fragilis group species with use of polymerase chain reaction fingerprinting and resistance profiles. Clin Infect Dis (1996) 1.31
Comparison of Etest to broth microdilution method for testing Streptococcus pneumoniae susceptibility to levofloxacin and three macrolides. Antimicrob Agents Chemother (1996) 1.27
Frequency of isolation of Porphyromonas species from infected dog and cat bite wounds in humans and their characterization by biochemical tests and arbitrarily primed-polymerase chain reaction fingerprinting. Clin Infect Dis (1996) 1.26
Eikenella corrodens in hand infections. J Hand Surg Am (1983) 1.24
Overproduction of a penicillin-binding protein is not the only mechanism of penicillin resistance in Enterococcus faecium. Antimicrob Agents Chemother (1992) 1.24
Social policy as a cause of childhood accidents: the children of lone mothers. BMJ (1995) 1.23
Effect of carbon dioxide on erythromycin. Antimicrob Agents Chemother (1983) 1.21
Short prereduced anaerobically sterilized (PRAS) biochemical scheme for identification of clinical isolates of bile-resistant Bacteroides species. J Clin Microbiol (1990) 1.21
Management of human and animal bite wounds. Emerg Med Clin North Am (1985) 1.21
Norfloxacin, a fluoroquinolone antibacterial agent. Classification, mechanism of action, and in vitro activity. Am J Med (1987) 1.21
Dog bite wounds and infection: a prospective clinical study. Ann Emerg Med (1980) 1.19
Susceptibility of Eikenella corrodens to newer beta-lactam antibiotics. Antimicrob Agents Chemother (1980) 1.18
Colonization of liver transplant recipients with KPC-producing Klebsiella pneumoniae is associated with high infection rates and excess mortality: a case-control analysis. Infection (2013) 1.17
Susceptibility of bite wound bacteria to seven oral antimicrobial agents, including RU-985, a new erythromycin: considerations in choosing empiric therapy. Antimicrob Agents Chemother (1986) 1.16
Risk compensation in children's activities: A pilot study. Paediatr Child Health (2004) 1.15
In vitro activities of a new des-fluoro(6) quinolone, garenoxacin, against clinical anaerobic bacteria. Antimicrob Agents Chemother (2003) 1.14
Resistance to moxifloxacin in toxigenic Clostridium difficile isolates is associated with mutations in gyrA. Antimicrob Agents Chemother (2001) 1.14
Identification and antimicrobial resistance patterns of clinical isolates of Clostridium clostridioforme, Clostridium innocuum, and Clostridium ramosum compared with those of clinical isolates of Clostridium perfringens. J Clin Microbiol (1995) 1.12
Identification and strain differentiation of 'Bacteroides fragilis group' species and Prevotella bivia by PCR fingerprinting. Anaerobe (1995) 1.12
First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia. Int J Tuberc Lung Dis (2012) 1.11
Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections. Antimicrob Agents Chemother (1985) 1.11
New horizons in the bacteriology, antimicrobial susceptibility and therapy of animal bite wounds. J Med Microbiol (1998) 1.11
Evaluation of the RapID CB Plus system for identification of Corynebacterium species and other gram-positive rods. J Clin Microbiol (1998) 1.10
Ligandinuria in nephrotoxic acute tubular necrosis. Kidney Int (1977) 1.10
Resistance of gram-negative bacilli as related to hospital use of antimicrobial agents. Antimicrob Agents Chemother (1983) 1.09
Comparative in vitro activities of amoxicillin-clavulanic acid and imipenem against anaerobic bacteria isolated from community hospitals. Antimicrob Agents Chemother (1986) 1.08
Controlled trial of social work in childhood chronic illness. Lancet (1987) 1.07
A selective medium for Fusobacterium spp. J Appl Bacteriol (1991) 1.07
Infections following clenched-fist injury: a new perspective. J Hand Surg Am (1978) 1.05
Comparison of microtiter broth dilution and agar dilution methods for susceptibility testing of Eikenella corrodens. Antimicrob Agents Chemother (1983) 1.04
Isolation of Eikenella corrodens from pulmonary infections. Am Rev Respir Dis (1979) 1.03
Effect of inoculum size on in vitro activity of norfloxacin against fecal anaerobic bacteria. Rationale for selective decontamination of the digestive tract. Am J Med (1987) 1.03
Legionnaires' disease. A cause of severe abscess-forming pneumonia. Am J Med (1979) 1.02
Bacteriology of rattlesnake venom and implications for therapy. J Infect Dis (1979) 1.02
Surveillance of resistance in bacteria causing community-acquired respiratory tract infections. Clin Microbiol Infect (2002) 1.00
Epidemiologic characterization of Pseudomonas aeruginosa in patients with cystic fibrosis. Clin Microbiol Infect (2000) 1.00
Fastidious anaerobe agar compared with Wilkins-Chalgren agar, brain heart infusion agar, and brucella agar for susceptibility testing of Fusobacterium species. Antimicrob Agents Chemother (1990) 1.00
Survival of anaerobic bacteria in various thioglycolate and chopped meat broth formulations. J Clin Microbiol (1995) 1.00
Incidence and clinical significance of anaerobic bacteremia in a community hospital. Clin Infect Dis (1993) 0.99
Outpatient therapy of bite wounds. Demographic data, bacteriology, and a prospective, randomized trial of amoxicillin/clavulanic acid versus penicillin +/- dicloxacillin. Int J Dermatol (1987) 0.99
Staphylococcus intermedius: clinical presentation of a new human dog bite pathogen. Ann Emerg Med (1989) 0.97
Susceptibility of Eikenella corrodens to newer and older quinolones. Antimicrob Agents Chemother (1986) 0.97
Cephalosporin therapy for salmonellosis. Questions of efficacy and cross resistance with ampicillin. Arch Intern Med (1986) 0.97
Isolation of Clostridium innocuum from cases of recurrent diarrhea in patients with prior Clostridium difficile associated diarrhea. Diagn Microbiol Infect Dis (2001) 0.95
Human babesiosis. Clinical and therapeutic considerations. JAMA (1982) 0.95
Activities of various beta-lactams and beta-lactam/beta-lactamase inhibitor combinations against Acinetobacter baumannii and Acinetobacter DNA group 3 strains. Clin Microbiol Infect (2005) 0.94
Evaluation of three rapid assays for detection of Clostridium difficile toxin A and toxin B in stool specimens. Eur J Clin Microbiol Infect Dis (2007) 0.94
Aerobic bacterial oral flora of garter snakes: development of normal flora and pathogenic potential for snakes and humans. J Clin Microbiol (1981) 0.93
Assessment of the excess risk of Salmonella dublin infection associated with the use of certified raw milk. Public Health Rep (1988) 0.93
bdhA-patD operon as a virulence determinant, revealed by a novel large-scale approach for identification of Legionella pneumophila mutants defective for amoeba infection. Appl Environ Microbiol (2009) 0.93
Endothelial cell compatibility of clarithromycin for intravenous use. Clin Biochem (1998) 0.92
Epidemiology and antifungal resistance in invasive candidiasis. Eur J Med Res (2011) 0.92
Infectious complications and therapy of bite wounds. J Am Podiatr Med Assoc (1989) 0.92
Growth characteristics and a novel method for identification (the WEE-TAB system) of Porphyromonas species isolated from infected dog and cat bite wounds in humans. J Clin Microbiol (1997) 0.91
Sinus infection due to Eikenella corrodens. Arch Otolaryngol (1978) 0.91
Antecedent use of fluoroquinolones is associated with resistance to moxifloxacin in Clostridium difficile. Clin Microbiol Infect (2003) 0.90
A real-time PCR assay for the differentiation of Candida species. J Appl Microbiol (2010) 0.90
In vitro activities of gatifloxacin, two other quinolones, and five nonquinolone antimicrobials against obligately anaerobic bacteria. Antimicrob Agents Chemother (1999) 0.90
Effect of control programs on cefazolin prescribing in a teaching hospital. Am J Hosp Pharm (1979) 0.90
Prevalence of Eikenella corrodens in dental plaque. J Clin Microbiol (1983) 0.90
Disseminated Mycobacterium marinum infection after renal transplantation. Ann Intern Med (1981) 0.90
The elements of medical malpractice: an overview. Clin Infect Dis (1996) 0.90
Pasteurella multocida subsp. multocida and P. multocida subsp. septica differentiation by PCR fingerprinting and alpha-glucosidase activity. J Clin Microbiol (2001) 0.88
Common bacterial skin infections. Diagnostic clues and therapeutic options. Postgrad Med (1993) 0.88
Susceptibility of Eikenella corrodens to penicillin, apalcillin, and twelve new cephalosporins. Antimicrob Agents Chemother (1984) 0.88
The standard of care is not so standard. Clin Infect Dis (1997) 0.88
Rapid identification of oral anaerobic bacteria cultivated from subgingival biofilm by MALDI-TOF-MS. Oral Microbiol Immunol (2008) 0.88